Evidence map›Paper›PMID 34409853›Full record

ArticleAntioxidants & redox signaling2022

Membrane Bound Peroxiredoxin-1 Serves as a Biomarker for

Sangeeta Jaiswal, Bishnu Joshi, Jing Chen, Fa Wang, Michael K Dame, Jason R Spence, Gina M Newsome, Erica L Katz, Yatrik M Shah, Sadeesh K Ramakrishnan and 5 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants & redox signaling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Sangeeta JaiswalDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-6095-1666
Bishnu JoshiDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Jing ChenDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Fa WangDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Michael K DameDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Jason R SpenceDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Gina M NewsomeDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Erica L KatzDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Yatrik M ShahDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Sadeesh K RamakrishnanDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Gaoming LiDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Miki LeeDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Henry D AppelmanDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Rork KuickDepartment of Biostatistics, and University of Michigan, Ann Arbor, Michigan, USA.
Thomas D WangDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1986 to 2021
$22.5M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
The role of HIF2alpha in colon carcinogenesisR01CA148828 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2010 to 2025
$5.2M
Microsystems imaging system for epithelial-derived cancer heterogeneityU01EB028235 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OLDHAM, KENN R, WANG, THOMAS D · 2019 to 2023
$2.9M
Early Detection of Colorectal Cancer on Near-Infrared Molecular EndoscopyR01CA193377 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, THOMAS D · 2016 to 2020
$2.1M
NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA148828NCI NIH HHS R01 CA193377NIBIB NIH HHS U01 EB028235NIDDK NIH HHS P30 DK034933NIDDK NIH HHS P30 DK089503
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenomaColorectal NeoplasmsPeroxiredoxinsBiomarkersHumansMutationProto-Oncogene Proteins B-rafBiomarkersPeroxiredoxinsPRDX1 protein, humanProto-Oncogene Proteins B-rafBRAFKCCoxidative stressperoxiredoxin-1sessile serrated adenoma

Identifiers

PMID34409853
PMCPMC8792500
OpenAlexW3195555766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.